HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 6 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,741,844 | +6.6% | 45,598 | +0.6% | 0.04% | +15.2% |
| Q2 2023 | $1,634,368 | -6.1% | 45,311 | -0.6% | 0.03% | -5.7% |
| Q1 2023 | $1,741,311 | -30.2% | 45,596 | +3.9% | 0.04% | -31.4% |
| Q4 2022 | $2,495,862 | +77.8% | 43,864 | +23.5% | 0.05% | +70.0% |
| Q3 2022 | $1,404,000 | -8.2% | 35,512 | +2.1% | 0.03% | +3.4% |
| Q2 2022 | $1,530,000 | +39.9% | 34,770 | +26.7% | 0.03% | +70.6% |
| Q1 2022 | $1,094,000 | -2.8% | 27,439 | -1.9% | 0.02% | +6.2% |
| Q4 2021 | $1,125,000 | +4.4% | 27,978 | +5.6% | 0.02% | 0.0% |
| Q3 2021 | $1,078,000 | -4.4% | 26,492 | +6.7% | 0.02% | -5.9% |
| Q2 2021 | $1,128,000 | +26.7% | 24,831 | +16.2% | 0.02% | +21.4% |
| Q1 2021 | $890,000 | +20.9% | 21,360 | +23.9% | 0.01% | +16.7% |
| Q4 2020 | $736,000 | +260.8% | 17,233 | +122.5% | 0.01% | +200.0% |
| Q3 2020 | $204,000 | +83.8% | 7,745 | +86.3% | 0.00% | +100.0% |
| Q2 2020 | $111,000 | – | 4,157 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |